|
Delayed
Nasdaq
23:03:22 10/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.9543 USD | +0.51% |
|
-8.24% | -27.70% |
| 11-06 | Lite Strategy, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2026 | CI |
| 10-13 | Lite Strategy, Inc. Launches Proof of Time Public Industry Archive | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 28.87M | - | - | - | - | - |
| 68.22B | |||||
| 59.82B | |||||
| 56.07B | |||||
| 47.67B | |||||
| 45.95B |
- Stock Market
- Stocks
- LITS Stock
- Charts Lite Strategy, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
